These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

431 related articles for article (PubMed ID: 38288116)

  • 121. Minimal change nephropathy and focal segmental glomerulosclerosis.
    Mathieson PW
    Semin Immunopathol; 2007 Nov; 29(4):415-26. PubMed ID: 17955243
    [TBL] [Abstract][Full Text] [Related]  

  • 122. Urinary podocyte markers of disease activity, therapeutic efficacy, and long-term outcomes in acute and chronic kidney diseases.
    Fukuda A; Sato Y; Shibata H; Fujimoto S; Wiggins RC
    Clin Exp Nephrol; 2024 Jun; 28(6):496-504. PubMed ID: 38402504
    [TBL] [Abstract][Full Text] [Related]  

  • 123. The Role of Podocytes and Podocyte-Associated Biomarkers in Diagnosis and Treatment of Diabetic Kidney Disease.
    Kravets I; Mallipattu SK
    J Endocr Soc; 2020 Apr; 4(4):bvaa029. PubMed ID: 32232184
    [TBL] [Abstract][Full Text] [Related]  

  • 124. Profilin1 is required for prevention of mitotic catastrophe in murine and human glomerular diseases.
    Tian X; Pedigo CE; Li K; Ma X; Bunda P; Pell J; Lek A; Gu J; Zhang Y; Medina Rangel PX; Li W; Schwartze E; Nagata S; Lerner G; Perincheri S; Priyadarshini A; Zhao H; Lek M; Menon MC; Fu R; Ishibe S
    J Clin Invest; 2023 Dec; 133(24):. PubMed ID: 37847555
    [TBL] [Abstract][Full Text] [Related]  

  • 125. The role of podocytes in lupus nephritis: Insights and implications.
    Ichinose K
    Clin Immunol; 2024 May; 262():110180. PubMed ID: 38462157
    [TBL] [Abstract][Full Text] [Related]  

  • 126. Mechanisms and implications of podocyte autophagy in chronic kidney disease.
    Njeim R; Merscher S; Fornoni A
    Am J Physiol Renal Physiol; 2024 Jun; 326(6):F877-F893. PubMed ID: 38601984
    [TBL] [Abstract][Full Text] [Related]  

  • 127. Podocyte-targeted therapies - progress and future directions.
    Meliambro K; He JC; Campbell KN
    Nat Rev Nephrol; 2024 May; ():. PubMed ID: 38724717
    [TBL] [Abstract][Full Text] [Related]  

  • 128. Podocyte Senescence and Aging.
    Shankland SJ; Rule AD; Kutz JN; Pippin JW; Wessely O
    Kidney360; 2023 Dec; 4(12):1784-1793. PubMed ID: 37950369
    [TBL] [Abstract][Full Text] [Related]  

  • 129. Transglutaminase-mediated stiffening of the glomerular basement membrane mitigates pressure-induced reductions in molecular sieving coefficient by reducing compression.
    Wang D; Ferrell N
    Matrix Biol; 2024 Jun; 130():47-55. PubMed ID: 38723871
    [TBL] [Abstract][Full Text] [Related]  

  • 130. Nonimmunologic targets of immunosuppressive agents in podocytes.
    Yoo TH; Fornoni A
    Kidney Res Clin Pract; 2015 Jun; 34(2):69-75. PubMed ID: 26484025
    [TBL] [Abstract][Full Text] [Related]  

  • 131. Oxysterol-binding protein like 7 deficiency leads to ER stress mediated apoptosis in podocytes and proteinuria.
    Duara J; Torres MF; Gurumani M; Molina David J; Njeim R; Kim JJ; Mitrofanova A; Ge M; Sloan AJ; Müller-Deile J; Schiffer M; Merscher S; Fornoni A
    Am J Physiol Renal Physiol; 2024 Jul; ():. PubMed ID: 38961844
    [TBL] [Abstract][Full Text] [Related]  

  • 132. HMGB 1 acetylation mediates trichloroethylene-induced immune kidney injury by facilitating endothelial cell-podocyte communication.
    Zhang X; Xie H; Liu Z; Zhang J; Deng L; Wu Q; Duan Y; Wang F; Wu C; Zhu Q
    Ecotoxicol Environ Saf; 2023 Jul; 259():115042. PubMed ID: 37216866
    [TBL] [Abstract][Full Text] [Related]  

  • 133. Podocyte Pathogenic Bone Morphogenetic Protein-2 Pathway and Immune Cell Behaviors in Primary Membranous Nephropathy.
    Cai A; Meng Y; Zhou H; Cai H; Shao X; Wang Q; Xu Y; Zhou Y; Zhou W; Chen L; Mou S
    Adv Sci (Weinh); 2024 May; ():e2404151. PubMed ID: 38785168
    [TBL] [Abstract][Full Text] [Related]  

  • 134. Brain-Derived Neurotrophic Factor-Loaded Low-Temperature-Sensitive liposomes as a drug delivery system for repairing podocyte damage.
    Huang X; Li M; Espinoza MIM; Zennaro C; Bossi F; Lonati C; Oldoni S; Castellano G; Alfieri C; Messa P; Cellesi F
    Int J Pharm; 2024 Jul; 660():124322. PubMed ID: 38866082
    [TBL] [Abstract][Full Text] [Related]  

  • 135. Repurposing drugs for diseases associated with podocyte dysfunction.
    Shankland SJ; Jefferson JA; Wessely O
    Kidney Int; 2023 Sep; 104(3):455-462. PubMed ID: 37290603
    [TBL] [Abstract][Full Text] [Related]  

  • 136. Preventing MMP23-mediated cleavage of podocyte RARRES1: a novel strategy to halt chronic kidney disease progression?
    Medina Rangel PX; Ishibe S
    Kidney Int; 2024 Jul; 106(1):16-18. PubMed ID: 38906649
    [TBL] [Abstract][Full Text] [Related]  

  • 137. Glomerular Elasticity and Gene Expression Patterns Define Two Phases of Alport Nephropathy.
    Yoon J; Liu Z; Alaba M; Bruggeman LA; Janmey P; Arana C; Ayenuyo O; Medeiros I; Nair V; Eddy S; Kretzler M; Henderson JM; Naik A; Chang AN; Miller RT
    bioRxiv; 2024 Jul; ():. PubMed ID: 38948788
    [TBL] [Abstract][Full Text] [Related]  

  • 138. Podocyte involvement in the pathogenesis of preterm-related long-term chronic kidney disease.
    Zhang L; Zheng J; Ding F
    Histol Histopathol; 2024 May; 39(5):557-564. PubMed ID: 37994826
    [TBL] [Abstract][Full Text] [Related]  

  • 139. The 14th International Podocyte Conference 2023: from podocyte biology to glomerular medicine.
    Koehler S; Hengel FE; Dumoulin B; Damashek L; Holzman LB; Susztak K; Huber TB;
    Kidney Int; 2024 May; 105(5):935-952. PubMed ID: 38447880
    [TBL] [Abstract][Full Text] [Related]  

  • 140. Transcriptomic profile of human iPSC-derived podocyte-like cells exposed to a panel of xenobiotics.
    Murphy C; Jennings P; Wilmes A
    Toxicol In Vitro; 2024 May; 97():105804. PubMed ID: 38447685
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.